Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:501 (30 August), doi:10.1136/bmj.327.7413.501-a
| The first 150 words of the full text of this article appear below. |
EditorEnstrom and Kabat's analysis has several omissions.1 First they accept that most epidemiological studies have found positive but not statistically significant relationships between environmental tobacco smoke, coronary heart disease, and lung cancer, but then argue against meta-analysis to establish a causal relation. This is precisely where systematic reviews, and sometimes meta-analysis, show considerable benefit by increasing power. Enstrom and Kabat say that publication bias may explain positive results in reviews; however, larger cohort studies, unlike small trials and reports, are more likely to be published, regardless of results.2 They do not explain heterogeneity between their findings and others, simply arguing that their cohort is large, and has more strengths. In fact, large prospective cohort studies like this may have greater losses to follow up, or more misclassification, over time.3
Misclassification, mentioned by the authors, may explain the apparent lack of association. Furthermore, the relative risks reported for active smoking and
Julia Critchley, lecturer
International Health Research Group, Liverpool School of Tropical Medicine, Liverpool L3 5QA juliac@liverpool.ac.uk
What can you learn from this BMJ paper? Read Leanne Tite's Paper+